| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/01/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 08/29/2022 |
SC 13D/A
| GARDNER LEWIS ASSET MANAGEMENT L P reports a 0% stake in La Jolla Pharmaceutical Co. |
| 08/29/2022 |
SC 13D
| GARDNER LEWIS ASSET MANAGEMENT L P reports a 6% stake in La Jolla Pharmaceutical Co. |
| 08/24/2022 |
SC 13D/A
| TANG CAPITAL PARTNERS LP reports a 0% stake in La Jolla Pharmaceutical Company |
| 08/23/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/23/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/23/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/23/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/23/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 08/22/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 08/22/2022 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 08/22/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/22/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 08/16/2022 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 08/15/2022 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/25/2022 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 07/25/2022 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 07/12/2022 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 07/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/11/2022 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 07/11/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 07/11/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 05/02/2022 |
10-K/A
| Annual Report for the period ended December 31, 2021 [amend] |
| 03/09/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 02/16/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 02/14/2022 |
SC 13G/A
| RTW INVESTMENTS, LP reports a 9.3% stake in La Jolla Pharmaceutical Company |
| 12/02/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/18/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 11/04/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 11/04/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 11/04/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
|